We use cookies to make sure our website better meets your expectations.
You can adjust your web browser's settings to stop accepting cookies. For further information, read our cookie policy.
SEARCH
IN Warsaw
Exchange Rates
Warsaw Stock Exchange - Indices
The Warsaw Voice » Society » December 21, 2012
Science
You have to be logged in to use the ReadSpeaker utility and listen to a text. It's free-of-charge. Just log in to the site or register if you are not registered user yet.
Innovative Medicine
December 21, 2012   
Article's tools:
Print

The Innovation for Healthcare conference, which took place in Warsaw Oct. 23, saw the release of a Report on Innovativeness of the Health Sector in Poland in 2012 with positive findings about the Polish market for medical services.

The conference was organized by the Institute of Economics and the Institute of Biocybernetics and Biomedical Engineering at the Polish Academy of Sciences (PAN) together with the MSN Science Network. The conference aimed to initiate a debate on innovation in Polish medicine among organizations and businesses linked with the healthcare system.

Innovation in medicine is a priority for the EU, as evidenced by its Horizon 2020 program focusing on medical technology and healthcare organization in EU member states. The EU has earmarked 9 billion euros for the program, which is scheduled to begin in 2014.

The Report on Innovativeness of the Health Sector in Poland in 2012, compiled by a team of analysts led by Prof. Tadeusz Baczko from the Institute of Economics, contains sector and microeconomic analyses and lists the largest investors in the Polish medical sector and the most innovative enterprises.

According to the report, the Polish market for medical services is developing rapidly and Polish researchers are innovative. However, the healthcare sector still needs to undergo thorough reforms before researchers in this country can make the most of their knowledge and skills. A key role in the process, according to conference participants, needs to be played by an efficient transfer of technology from research laboratories to business. A major factor that stands in the way is that the payback period for investment in the medical sector is longer than in other sectors of the economy.

According to Baczko, many innovative companies in Poland work in extremely difficult conditions. In his opinion, Poland still lacks a policy whereby innovative companies would get extensive support from the government and local authorities. “The best opportunities for development are offered by the still-unmet needs of patients, because there are no limits to demand for health services,” Baczko told the conference.

The conference comprised three panel discussions. The first discussion concerned projects undertaken jointly by science and business; the second dealt with the international aspect of healthcare services, such as “medical tourism;” and the third panel discussion focused on certification, intellectual property and standardization.
© The Warsaw Voice 2010-2018
E-mail Marketing Powered by SARE